Variant report
Variant | esv3434705 |
---|---|
Chromosome Location | chr6:54232193-54234741 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-KLHL31-4 | chr6:54234709-54234769 | ENSG00000228231.2 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113689730 | chr6:54232204-54232205 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181258599 | chr6:54232214-54232215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185718391 | chr6:54232230-54232231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs41413844 | chr6:54232238-54232239 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs527536130 | chr6:54232251-54232252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547386758 | chr6:54232347-54232348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564241748 | chr6:54232364-54232365 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190669567 | chr6:54232384-54232385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146355349 | chr6:54232395-54232396 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569408835 | chr6:54232401-54232402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184048184 | chr6:54232415-54232416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548611228 | chr6:54232509-54232510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568364380 | chr6:54232566-54232567 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188896171 | chr6:54232592-54232593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7750024 | chr6:54232671-54232672 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs148386965 | chr6:54232703-54232704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140594772 | chr6:54232719-54232720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539671008 | chr6:54232746-54232747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs73446613 | chr6:54232818-54232819 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs7750323 | chr6:54232847-54232848 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs541454766 | chr6:54232860-54232861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377663757 | chr6:54232872-54232873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9474824 | chr6:54232878-54232879 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs9395947 | chr6:54232900-54232901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs151080354 | chr6:54232911-54232912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562029450 | chr6:54232946-54232947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs9395948 | chr6:54232987-54232988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372106643 | chr6:54233027-54233028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575817949 | chr6:54233046-54233047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113362700 | chr6:54233062-54233063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541293901 | chr6:54233100-54233101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564403567 | chr6:54233128-54233129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190974934 | chr6:54233157-54233158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550042783 | chr6:54233230-54233231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538234894 | chr6:54233232-54233233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182438224 | chr6:54233262-54233263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142467297 | chr6:54233311-54233312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571124177 | chr6:54233380-54233381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187957235 | chr6:54233403-54233404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191626203 | chr6:54233449-54233450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184209211 | chr6:54233465-54233466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570841898 | chr6:54233483-54233484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs539635156 | chr6:54233515-54233516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143165704 | chr6:54233538-54233539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556383945 | chr6:54233558-54233559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371121531 | chr6:54233567-54233568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187488540 | chr6:54233577-54233578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376151559 | chr6:54233602-54233603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555194985 | chr6:54233641-54233642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571988607 | chr6:54233682-54233683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:54211800-54256200 | Weak transcription | Fetal Intestine Large | intestine |
2 | chr6:54212000-54257400 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
3 | chr6:54231400-54232400 | Enhancers | NHEK | skin |
4 | chr6:54231400-54232400 | Enhancers | Osteobl | bone |
5 | chr6:54231400-54232600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr6:54231400-54232600 | Enhancers | HMEC | breast |
7 | chr6:54231400-54232800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr6:54231600-54232400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr6:54231600-54232800 | Enhancers | HUVEC | blood vessel |
10 | chr6:54231800-54232400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr6:54231800-54232400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr6:54232000-54232200 | Flanking Active TSS | NH-A | brain |
13 | chr6:54232200-54232400 | Enhancers | NH-A | brain |